Picture a pharmacist reading a CDSCO alert about a spurious batch of a widely-sold antihypertensive. The batch number on the alert matches stock sitting in the storage rack — stock already billed to customers that week. The distributor has no recall protocol. The pharmacy has no batch log. Days of phone calls follow, along with unsellable inventory, the risk of a legal notice, and the kind of customer distrust that does not repair itself quickly.
That is not an edge case. CDSCO publishes spurious and not-of-standard-quality (NSQ) drug alerts regularly, and the distribution chain between manufacturer and retail counter is long enough that a contaminated or counterfeit batch can arrive looking entirely legitimate — correct packaging, plausible hologram, matching MRP sticker.
If you are reading this after finding a suspicious strip on your shelf, or after a customer returned something that felt wrong, this post is about what you can actually do at the counter — and what systems make that possible.
---
Your Schedule H/H1 Records Are Your First Line of Proof — and Many Pharmacies Run Them Blind
Picture a pharmacy owner who keeps the Schedule H1 register in a spiral notebook. An inspector asks for entries going back 18 months. The book is there. What is missing is the batch number — it was never filled in consistently.
Under Rule 65 of the Drugs and Cosmetics Rules, every Schedule H and H1 supply must be recorded with the batch number and expiry, and Schedule H1 supplies also go in a separate register kept for three years. Selling a Schedule H1 drug without a prescription is punishable under Section 27(d) of the Drugs and Cosmetics Act, 1940, with imprisonment of one to two years and a fine of not less than ₹20,000; offences involving spurious drugs are punished far more severely. The record is not optional, and "batch number" is not optional within it.
The connection to spurious drugs is direct: if a CDSCO alert identifies batch number XYZ of a particular molecule, a pharmacy with a properly maintained batch log can answer within minutes whether that batch is on its shelves or has been dispensed. A pharmacy running a paper register with inconsistent batch entries cannot. In a drug inspector visit following a counterfeit complaint, that gap between knowing and not-knowing is the difference between a cleared record and a show-cause notice.
---
The Visual Check at the Counter Catches Only the Obvious Fakes
The standard retail counter check for a suspicious strip looks like this:
- Check the hologram (present / absent / looks off)
- Check the print quality on the carton
- Check whether the batch number and manufacturing date are legible and consistent
- Check whether the MRP matches what the system shows
This is not nothing. Grossly fake packaging — blurry fonts, wrong logo placement, missing branding elements — does get caught this way. But a well-produced counterfeit, or a genuinely spurious batch from a licensed manufacturer that used substandard raw material, passes every visual check. The hologram is real. The batch number exists. The strip looks identical to a legitimate one.
The only check that goes beyond the visual is batch verification against the manufacturer's database or against a CDSCO NSQ / spurious drug alert. Some manufacturers maintain QR-code or SMS-based batch verification. If the strip has that QR code, scanning it takes seconds and gives the manufacturer's own confirmation. If the strip does not — and many domestic generics do not — the only available cross-reference is the CDSCO alert list.
The honest answer is that a retail counter cannot run a laboratory test. What it can do is close the gap between "I checked visually" and "I checked this batch number against every available public database before dispensing." Many pharmacies do not do the second step because it requires knowing where to look and having the batch number recorded in the first place.
---
A Single Counterfeit Incident Carries Costs That Go Well Beyond the Strip Price
The financial exposure from a spurious medicine incident is layered in a way that is easy to underestimate.
The direct cost — inventory you cannot sell and cannot easily return — is the smallest layer. Painful but containable.
The regulatory cost is larger. A CDSCO inspection triggered by a customer complaint, a drug inspector visit, or a tip from a competitor can result in a show-cause notice, a license suspension, or a fine under Section 27. Legal representation for a D&C Act notice costs money on its own, and a licence suspension of even two weeks means two weeks of billing that never happens.
The reputational cost is the hardest to quantify and the slowest to recover. A patient complaint that spreads through a local WhatsApp group can cost a neighbourhood pharmacy its repeat prescriptions, and that loss is not recoverable from a distributor's credit note.
---
What Operations Look Like When Batch Tracking Is Not an Afterthought
Here is the difference between two pharmacies receiving the same CDSCO alert for a spurious batch of a Schedule H molecule:
| Step | Pharmacy without batch tracking | Pharmacy with batch tracking |
|---|
| Alert received | Owner sees it on WhatsApp, uncertain whether affected | System cross-references alert batch number against purchase records |
| Affected stock identified | Manual shelf search | Found by looking up the batch number |
| Dispensed units traced | Not possible without manual bill review | Dispensed quantity pulled from batch-level sales log |
| Distributor return initiated | Verbal call, no documentation | Purchase entry with batch number available for written return claim |
| Drug inspector inquiry | Partial records, risk of compliance gap | Complete Schedule H log with batch, quantity, supplier |
| Total time to close | Days, high stress | Much faster, documented |
The difference is not about having expensive software. It is about whether batch numbers are captured at purchase and linked to sales at the item level. Many pharmacy billing systems record batch numbers somewhere in the purchase entry. What they often do not do is surface that information automatically when an alert comes in, or flag a batch at point of sale if it appears on a watch list.
The pharmacies that handle counterfeit incidents cleanly are the ones that built batch-level discipline before the incident — not in response to it.
---
How Nesayo Helps When a CDSCO Alert Comes In
To be clear about the limits first: as of September 2026, Nesayo does not read CDSCO alerts or flag an alerted batch on its own. The check against the alert list is still yours to make. What Nesayo gives you is the batch-level record that makes that check quick.
Batch numbers are recorded when stock comes in — typed, imported from a file, or read from a photo of the purchase invoice. When an alert names a batch, search the medicine on the stock page and every batch you hold is listed with its batch number, quantity and expiry. Every bill line is sold from a specific batch, and Schedule H1 sales are logged at billing with the patient, prescriber, medicine, batch and quantity (the pharmacist adds the prescriber's address). You are not searching through a paper register or reconstructing anything from memory.
The billing itself is free on Nesayo — no subscription required for the core counter. FEFO (first-expiry, first-out) batch selection is built into every bill, so every bill line records the batch it was deducted from — the earliest-expiring one on the system, which is the pack the counter should hand over — and a batch whose expiry month has passed is refused at billing. On the Full plan (₹549 per month as of October 2026; see nesayo.com/pricing for current rates), the Morning Briefing and Expiry Guard agents put stock that needs attention in front of the pharmacist each morning.
Voice billing in Hindi and English (beta, on paid plans) is relevant not to counterfeit detection specifically but to the broader point: a system the counter staff actually uses consistently is one that collects the batch data that makes detection possible.
---
The Choice Is Between Building the Record Before the Incident or Explaining the Gap After
If a spurious batch comes through your counter this month — and the CDSCO alert database suggests it is a question of when, not if — your outcome depends almost entirely on records you built before it arrived. A complete batch log means a quick, documented resolution. An incomplete one means days of reconstruction, regulatory exposure, and a distributor who has no obligation to take back stock you cannot document.
The pharmacies that absorb the worst losses from counterfeit incidents are not the ones that stocked the spurious product. They are the ones that could not prove what they did with it.
Spend 2 minutes at nesayo.com/demo — a sample pharmacy is pre-loaded, no signup required. You will see every batch on the shelf with its number, quantity and expiry, and how each bill line records the batch it was sold from.
---
FAQ
How do I check if a medicine batch is spurious or NSQ in India?
The CDSCO maintains a public database of spurious, adulterated, and not-of-standard-quality drug alerts at cdsco.gov.in. You can search by brand name, manufacturer, or batch number. Some state drug controllers also publish separate alert lists. Checking this database against your purchase batch numbers before dispensing is the only free, publicly available cross-reference a retail counter can perform without laboratory testing.
What is the legal penalty for a pharmacy that sells a spurious drug unknowingly?
Selling a spurious drug is among the gravest offences under Section 27 of the Drugs and Cosmetics Act, with long prison terms and heavy fines. If you can demonstrate that you purchased from a licensed distributor, maintained proper records, stored the stock properly, and had no reasonable means to detect the spurious nature, that documentation matters a great deal to how the case proceeds. This is a legal question — consult a drug law advocate for advice specific to your situation.
Is FEFO a legal requirement for Indian retail pharmacies?
FEFO (first-expiry, first-out) is not explicitly mandated by name in the Drugs and Cosmetics Rules for retail pharmacies, but Schedule M (Good Manufacturing Practices) and CDSCO's Good Distribution Practices guidance reference batch-rotation discipline as standard practice. More practically, selling a later-expiry batch while an earlier-expiry batch sits in stock creates unnecessary expiry write-off exposure.
What can a pharmacist actually verify on a strip at the counter without lab equipment?
A pharmacist can verify: packaging print quality and font consistency, hologram presence and basic visual authenticity, batch number and expiry date legibility, MRP alignment with purchase records, and — for manufacturers who support it — QR-code or SMS-based batch authentication. What a retail counter cannot verify without laboratory analysis: actual drug composition, potency, dissolution rate, or microbiological contamination.
How does CDSCO's drug alert system work and how often are alerts issued?
CDSCO issues drug quality alerts on its website when state drug testing laboratories or the Central Drugs Laboratory identify a product as spurious, adulterated, or not of standard quality (NSQ). Alerts are typically issued after a sample drawn from the market fails testing. CDSCO publishes these alert lists regularly. There is no automatic notification to retail pharmacies; checking the database requires a manual visit to cdsco.gov.in or subscribing to a third-party alert aggregator.
Can a distributor be held liable if they supplied spurious medicines to my pharmacy?
A licensed distributor who supplied spurious drugs is liable under the D&C Act if it can be shown they knew or should have known. As a retailer, you have a right to seek indemnification through your purchase agreement, and a properly documented purchase record — supplier name, invoice number, batch number — is essential to making that claim. In practice, recovery depends heavily on how quickly you can document the chain of custody. Verify your specific rights with a drug law advocate or your state chemists' association.
What records does a drug inspector look for when investigating a counterfeit medicine complaint at a pharmacy?
Inspectors typically ask for: the Schedule H/H1 register with batch number, quantity, patient name (for prescription drugs), and prescriber details for all relevant entries; purchase invoices from the distributor for the flagged batch; any return correspondence with the distributor; and your drug license. Under Rule 65 of the D&C Rules, the Schedule H1 register must be kept for three years. Missing or incomplete batch entries are exactly the kind of gap that turns a routine enquiry into a longer one.
Does Nesayo automatically cross-reference CDSCO alerts against my stock?
No. As of September 2026, Nesayo does not read CDSCO alerts or flag an alerted batch automatically; the cross-check against the CDSCO list is still a manual step. What Nesayo does is keep the batch-level data that makes that manual check fast: batch numbers are recorded when stock comes in, every bill line is sold from a specific batch (earliest expiry first), and Schedule H1 sales are logged at billing with the batch. Check nesayo.com/pricing for the current feature set, as this may change.